Geoffrey S. Findlay, Ph.D.
Geoff Findlay, Ph.D., joined Fulbright in 2003 where he worked as a patent agent and technical advisor for nine years. Geoff holds an undergraduate degree in chemistry from Williams College and a Ph.D. in molecular neuroscience from the University of Texas at Austin. Geoff is a member of the Phi Kappa Phi honor society and was awarded scholar athlete honors during his undergraduate studies. Geoff was awarded multiple competitive fellowships and grants, and his work has been featured in journals including The Journal of Neuroscience. Geoff also worked at a Phase I lab and performed cancer research. As a patent professional, Geoff has focused on biotechnology patent prosecution, patentability searches, and freedom-to-operate analyses for a wide range of technologies including next-generation sequencing, cancer therapies, antimicrobial compositions, polymers, small molecule therapeutics, cartilage technologies, imaging, antibody therapeutics, stem cell technologies, pharmaceutical compositions, and other biotechnologies.
- Intellectual Property and Technology
- Science & Technology
Prior to joining the Parker Highlander, Geoff served as a Technical Advisor and Patent Agent for 9 years at the Austin office of Fulbright & Jaworski LLP. Geoff’s technical background ranges from chemistry to molecular biology and the creation and characterization of genetically altered animals. His experience includes electrophysiology, generation and characterization of mutant brain receptors, physical chemistry research, experience at a Phase I drug development lab, cancer research focusing on genetics, and molecular neuropharmacology. He has also been awarded several competitive fellowships from NIH/NIAAA and private sponsors.
Professional Activities & Memberships
- Austin Intellectual Property Lawyers Association (Austin IPLA)
Findlay G.S., Phelan R., Roberts M.T., Homanics G.E., Bergeson S.E., Lopreato G.F., Mihic S.J., Blednov Y.A., and Harris R.A., “Glycine Receptor Knock-in Mice and Hyperekplexia-Like Phenotypes: Comparisons with the Null Mutant,” J Neurosci, 23(22): 8051-9, 2003
- Findlay G.S., Wick M.J., Mascia M.P., Wallace D., Miller G.W., Harris R.A., Blednov Y.A., “Transgenic Expression of a Mutant Glycine Receptor Decreases Alcohol Sensitivity of Mice,” J Pharmacol Exp Ther. 300(2): 526-34, 2002
- Findlay G.S., Harris R.A., and Blednov Y.A., “Transgenic Glycine Receptor Î±1 (S267Q) Mutant Mice: Chloride Uptake and Acoustic Startle Responses,” Brain Res. Submitted, 2003
- Findlay G.S., Ueno S., Harrison N.L., Harris R.A., “Allosteric Modulation in Spontaneously Active Mutant Gamma-Aminobutyric Acid(A) Receptors,” Neurosci Lett. 305(1): 77-80, 2001
- Blednov Y.A., Walker D., Alva H., Creech K., Findlay G., Harris R.A., “GABAA Receptor Alpha 1 and Beta 2 Subunit Null Mutant Mice: Behavioral Responses to Ethanol,” J Pharmacol Exp Ther. Jun;305(3): 854-63, 2003
- Ueno S., Harris R.A., Messing R.O., Sanchez-Perez A.M., Hodge C.W., McMahon T., Wang D., Mehmert K.K., Kelley S.P., Haywood A., Olive M.F., Buck K.J., Hood H.M., Blednov Y., Findlay G., Mascia M.P., “Alcohol Actions on GABA(A) Receptors: From Protein Structure to Mouse Behavior,” Alcohol Clin Exp Res. 25: 76S-81S. Review, 2001
- Findlay G.S., Ueno S., Harrison N.L., Harris R.A., “Allosteric Modulation in Spontaneously Active Mutant Gamma-Aminobutyric Acid(A) Receptors [corrected],” Neurosci Lett. 293(3): 155-8, 2000
- Katerina V., Savelieva, W., Michael Caudle, Findlay G.S., Caron M.G., Miller G.W., “Decreased Ethanol Preference and Consumption in Dopamine Transporter Female Knock-Out Mice,” Alcohol Clin Exp Res. 26(6): 758-64, 2002
Contributing Reviewer for:
- Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, Bethesda, MD
- The British Journal of Pharmacology, British Pharmacological Society, London, England
- Alcoholism Clinical and Experimental Research, Research Society on Alcoholism (RSA), Austin, TX
- Telethon Italy, Comitato Telethon Fondazione Onlus – Fondazione Telethon, Via G. Saliceto, 5a – 00161 Rome, Italy
- Wiley and Sons, “What’s Wrong with My Mouse: Behavioral Phenotyping of Transgenic and Knockout Mice,” 2nd Edition, Geoffrey S. Findlay reviewed planned changes and additions to new version.
- 2003 – Ph.D., Neuroscience, University of Texas at Austin
- 1997 – B.A., Chemistry, Williams College
While working on his Ph.D., Geoff was awarded the prestigious Phi Kappa Phi Honor Society membership. He was also awarded numerous fellowships and scholarships.
- Intellectual Property and Patents; Speaker for BIO 381K (51840) and Neuro 394P (57573). The University of Texas at Austin. February 24, 2016
- Intellectual Property and Patents; Speaker for PGSA (UT-Austin), UT San Antonio, and Dell Pediatric Research Institute (DPRI). The University of Texas at Austin. November 18, 2015
- Intellectual Property and Patents; Speaker for BIO 381K (51840) and Neuro 394P (57573). The University of Texas at Austin. March 5, 2014
- Intellectual Property and Patents; Speaker for BIO 381K (51840) and Neuro 394P (57573). The University of Texas at Austin. February 22, 2012
- Intellectual Property and Patents; Speaker for BIO 381K (51840) and Neuro 394P (57573). The University of Texas at Austin. February 24, 2010
- Intellectual Property and Patents; for BIO 381K (51840) and Neuro 394P (57573). The University of Texas at Austin. February 25, 2008
- Intellectual Property: Putting the Pieces Together; Presentation as part of BIO 381K and Neuro 394P. The University of Texas at Austin. February 24, 2007
- Perspectives on Intellectual Property; Sponsored by the NGSA. The University of Texas at Austin. December 6, 2004